Blog

GeneWorks is excited to invite you to attend this in-person event where you will learn more about how to unlock the power of fluid biomarkers! The NULISA™ platform is the future of protein biomarker discovery and analysis. This next-generation proteomics technology is the first to deliver on all four liquid biopsy protein profiling needs with best-in-class capabilities: Attomolar (low fg/ml) sensitivity and low cross-reactivity ~10-log dy… Read more

Medieval maps of the world included drawings of fearsome dragons and sea monsters to warn of uncharted territory. These gaps have long since been filled by daring explorers, and what was once unknown, has become familiar.Visionary researchers and clinicians using powerful spatial biology tools are doing the same for the vast unknown and uncharted territory in tumors, their microenvironments, and chronic diseases. The location, function, and inter… Read more

Improving Alzheimer’s Disease (AD) diagnosis is the first essential step for improving patient care and quality of life. Early, accurate diagnosis is instrumental in giving people with AD and their families access to support, and the ability to participate in their own care decisions1.Currently, clinicians diagnose AD using a combination of symptom presentation, brain imaging, and the detection of CSF biomarkers for AD. Despite their effective di… Read more